Endo International continued to reshape its C-suite with the appointment of Blaise Coleman as the Chester County specialty pharmaceutical company’s executive vice president and chief financial officer.
Coleman had been Endo’s (NASDAQ: ENDP) interim CFO since late November following the departure of former CFO Sukefu Upadhyay in October. Upadhyay,whose departure came approximately a month after Paul V. Campanelli replaced Rajiv De Silva as the Endo’s president and CEO, left to become senior vice president…
Source: bizjournals.com